Concepedia
Statistics
Publications
72
Citations
4.1K
H-Index
37
Active since
2004
Affiliations
University of Nottingham(Current)
Nottingham University Hospitals NHS Trust
Nottingham City Hospital
Menoufia University
Nottingham Trent University
Mohammed A. Aleskandarany is an author at University of Nottingham specializing in oncology, medicine, and molecular oncology.
Publications per year
2004–2022
Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
Emad A. Rakha, Somaia Elsheikh, Mohammed A. Aleskandarany et al. · Clinical Cancer Research · 2009 · 485 citations
Medicine, Oncology, Pathology +11
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen
Hany Onsy Habashy, Desmond G. Powe, Cindy M. Staka et al. · Breast Cancer Research and Treatment · 2009 · 239 citations · Full text
Medicine, Cancer Biology, Oncology +13
CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome
Somaia Elsheikh, Andrew R. Green, Mohammed A. Aleskandarany et al. · Breast Cancer Research and Treatment · 2007 · 157 citations
Medicine, Molecular Biology, Oncology +17
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
Andrew R. Green, Mohammed A. Aleskandarany, Devika Agarwal et al. · British Journal of Cancer · 2016 · 127 citations · Full text
Medicine, Molecular Biology, Oncology +13
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Mohammed A. Aleskandarany, Andrew R. Green, Ahmed Benhasouna et al. · Breast Cancer Research · 2012 · 126 citations · Full text
Medicine, Oncology, Pathology +17
1–5 of 72